TCV Trust & Wealth Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-2,650
| Closed | -$267K | – | 192 |
|
|
2023
Q2 | $267K | Sell |
2,650
-1,729
| -39% | -$174K | 0.03% | 163 |
|
|
2023
Q1 | $403K | Sell |
4,379
-104,921
| -96% | -$9.65M | 0.04% | 147 |
|
|
2022
Q4 | $9.92M | Buy |
109,300
+387
| +0.4% | +$35.1K | 1.13% | 32 |
|
|
2022
Q3 | $8.28M | Buy |
108,913
+4,389
| +4% | +$334K | 1.05% | 38 |
|
|
2022
Q2 | $8.84M | Buy |
104,524
+4,439
| +4% | +$375K | 1.06% | 36 |
|
|
2022
Q1 | $8.78M | Sell |
100,085
-516
| -0.5% | -$45.3K | 0.94% | 40 |
|
|
2021
Q4 | $8.8M | Sell |
100,601
-2,034
| -2% | -$178K | 0.88% | 43 |
|
|
2021
Q3 | $8.39M | Buy |
102,635
+1,405
| +1% | +$115K | 0.93% | 42 |
|
|
2021
Q2 | $9.3M | Buy |
101,230
+3,159
| +3% | +$290K | 1.02% | 41 |
|
|
2021
Q1 | $8.38M | Buy |
98,071
+764
| +0.8% | +$65.3K | 0.97% | 41 |
|
|
2020
Q4 | $9.19M | Buy |
97,307
+1,558
| +2% | +$147K | 1.11% | 36 |
|
|
2020
Q3 | $8.33M | Buy |
95,749
+1,608
| +2% | +$140K | 1.12% | 35 |
|
|
2020
Q2 | $8.22M | Buy |
94,141
+3,814
| +4% | +$333K | 1.17% | 36 |
|
|
2020
Q1 | $7.45M | Buy |
90,327
+1,673
| +2% | +$138K | 1.22% | 33 |
|
|
2019
Q4 | $8.39M | Buy |
+88,654
| New | +$8.39M | 1.02% | 37 |
|